ABSTRACT
OBJECTIVE: Lichen sclerosus is a chronic, inflammatory, progressive skin disease predominantly affecting anogenital areas. Vulvar lichen sclerosus (VLS) is one of the most common conditions treated in vulvar clinics; most patients report distressing symptoms of itching, burning, stinging, and pain (particularly during or after sexual intercourse). A preliminary, prospective, single-center study was performed to investigate the efficacy of hyaluronan hybrid cooperative complex (HCC) comprising high and low molecular weight hyaluronic acid to treat menopausal women with VLS. PATIENTS AND METHODS: Patients (N = 30) received two HCC injections at 32 mg/ml (one month apart). At baseline and one and six months after treatment, patients completed validated psychometric questionnaires to assess their self-reported pain, itching, and dryness using the Visual Analogue Scale (VAS) and sexual function by the Female Sexual Function Index (FSFI). RESULTS: After treatment with HCC, no side effects or complications were reported. VAS scores showed a trend towards reduced pain and itching intensity, and there was a statistically significant reduction in median VAS score for dryness at follow-up vs. baseline (p=0.038). For sexual function, there was a statistically significant improvement in lubrication (p=0.001) and orgasm (p=0.001) FSFI domains. CONCLUSIONS: Overall, this preliminary study demonstrated the promising efficacy of HCC in menopausal women with VLS without side effects.
Subject(s)
Skin Diseases , Vulvar Lichen Sclerosus , Humans , Female , Vulvar Lichen Sclerosus/drug therapy , Vulvar Lichen Sclerosus/complications , Prospective Studies , Vulva , Pruritus/complications , PainABSTRACT
The case of a woman who suffered from CSU and prurigo Besnier, with a history of chronic hyper-eosinophilia, ulcerative colitis and thyroiditis, unresponsive to anti-histamines and steroids is reported. The patient received omalizumab treatment, and obtained resolution of urticaria along with improvement of cutaneous symptoms of prurigo.
Subject(s)
Anti-Allergic Agents/therapeutic use , Colitis, Ulcerative/drug therapy , Dermatitis, Atopic/drug therapy , Hypereosinophilic Syndrome/drug therapy , Omalizumab/therapeutic use , Prurigo/drug therapy , Urticaria/drug therapy , Chronic Disease , Colitis, Ulcerative/diagnosis , Dermatitis, Atopic/diagnosis , Female , Humans , Hypereosinophilic Syndrome/diagnosis , Middle Aged , Prurigo/diagnosis , Urticaria/diagnosisABSTRACT
Alitretinoin is a unique retinoid authorised for the treatment of adults with severe chronic hand eczema (CHE) refractory to potent topical steroids. The most common adverse events (AEs) were typical class effects of oral retinoids including headache, flushing and skin disorders. To our knowledge, there are no cases of sensitization to alitretinoin reported in literature. We present a case of sensitization to alitretinoin.
Subject(s)
Drug Eruptions/etiology , Hand Dermatoses/etiology , Tretinoin/adverse effects , Adult , Alitretinoin , Female , HumansABSTRACT
Systemic contact dermatitis (SCD) can be caused by nickel in sensitized subjects. Nickel allergy is commonly characterized by localized reactions ensuring cutaneous exposure to this element. Systemic reactions can occur after dietary nickel ingestion. We report a case of a woman with Systemic Contact Dermatitis due to nickel.
